A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocyte lesions

Pathologica

Volumn 101, Issue 5, 2009, Pages 169-174

  Clemente, C ^a   Bettio, D ^b   Venci, A ^b   Scopsi, L ^c   Rao, S ^a   Ferrari, A ^a   Piris, A ^d   Mihm Jr , M C ^d  

^a Div of Pathology and Cytopathology   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c Cancer Genetics Service   (Italy)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Differential diagnosis; In situ hybridization; Melanocytic lesions; Melanoma; Molecular genetics

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; INFANT; MALE; MELANOMA; MIDDLE AGED; PIGMENTED NEVUS; SENSITIVITY AND SPECIFICITY; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; MELANOMA; MIDDLE AGED; NEVUS, PIGMENTED; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 76149103898     PISSN: 00312983     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Roesch A, Wittschier S, Becker B, Landthaler M, Vogt T. Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating nevi. Mod Pathol 2006;19:1378-1385
2. King MS, Porchia SJ, Hiatt KM. Differentiating spitzoid melanomas from Spitz nevi through CD99 expression. J Cutan Pathol 2007;34:576-580
3. Zembowicz A, Knoepp SM, Bei T, Stergiopoulos S, Eng C, Mihm MC, et al. Loss of expression of protein kinase a regulatory subunit 1 alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am J Surg Pathol 2007;31:1764-1775
4. Orchard GE. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma. Histochem J 2000;32:475-481
5. Li LX, Crotty KA, McCarthy SW, Palmer AA, Kril JJ. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions. Am J Dermatopathol 2000;22:489-495
6. Kazakov DV, Kutzner H, Rütten A, Michal M, Requena L, Burg G, et al. The anti-MAGE antibody B57 as a diagnostic marker in melanocytic lesions. Am J Dermatopathol 2004;26:102-107
7. Fröhlich E, Mack AF, Garbe C, Klessen C. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas. Br J Dermatol 2005;153:1159-1165
8. Nasr MR, El-Zammar O. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Am J Dermatopathol 2008;30:117-122
9. van Dijk MC, Aben KK, van Hees F, Klaasen A, Blokx WA, Kiemeney LA, et al. Expert review remains important in the histopathological diagnosis of cutaneous melanocytic lesions. Histopathology 2000;52:139-146
10. Lodha S, Saggar S, Celebi JT, Silvers DN. Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting. J Cutan Pathol 2008;35:349-352
11. Barnhill RL, Argenyi Z, Berwick M, Duray PH, Erickson L, Guitart J, et al. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ( "malignant blue nevus"). Am J Surg Pathol 2008;32:36-44.
12. Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 2003;163:1765-1770
13. Bastian BC. Molecular genetics of melanocytic neoplasia: practical applications for diagnosis. Pathology. 2004:36:458-461
14. Bauer J, Bastian BC. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol Ther 2006;19:40-49
15. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353:2135-2147
16. Viros A, Fridlyand J, Bauer J, Lasithiotakis K, Garbe C, Pinkel D, et al. Improving melanoma classification by integrating genetic and morphologic features. PLoS Med 2008;5:e120.
17. Moore SR, Persons DL, Sosman JA, Bobadilla D, Bedell V, Smith DD, et al. Detection of copy number alterations in metastatic melanoma by a DNA fluorescence in situ hybridization probe panel and array comparative genomic hybridization: a southwest oncology group study (S9431). Clin Cancer Res 2008;14:2927-2935
18. Koynova DK, Jordanova ES, Milev AD, Dijkman R, Kirov KS, Toncheva DI, et al. Gene-specific fluorescence in-situ hybridization analyis on tissue microarray to refine the region of chromosome 20q amplification in melanoma. Melanoma Res. 2007;17:37-41.
19. http://www.genecards.org/cgi-bin/carddisp.pl?gene=RREB1 (accessed December 2, 2008).
20. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=189990 (accessed December 2, 2008).
21. http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=168461 (accessed December 2, 2008).
22. Morey AL, Murali R, McCarthy SW, Mann GJ, Scolyer RA. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation. Pathology 2009;41:383-387
23. Newman MD, Lertsburapa T, Mirzabeigi M, Mafee M, Guitart J, Gerami P. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma. Mod Pathol 2009;22:989-995
24. Gerami P, Jewell SS, Morrison LE, Blondin B, Schulz J, Ruffalo T, et al. Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma. Am J Surg Pathol 2009;33:1146-1156
25. King R, Page RN, Googe PB, Mihm MC Jr. Lentiginous melanoma: a histologic pattern of melanoma to be distinguished from lentiginous nevus. Mod Pathol 2005;18:1397-1401
26. Davis T, Zembowicz A. Histological evolution of lentiginous melanoma: a report of five new cases. J Cutan Pathol 2007;34:296-300.
27. Zembowicz A, Carney JA, Mihm MC. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol 2004;28:31-40.
28. de Almeida LS, Requena L, Rütten A, Kutzner H, Garbe C, Pestana D, et al. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases. Am J Dermatopathol 2008;30:207-215
29. Schmoeckel C, Castro CE, Braun-Falco O. Nevoid malignant melanoma. Arch Dermatol Res 1985;277:362-369
30. Lens MB, Newton-Bishop JA, Boon AP. Desmoplastic malignant melanoma: a systematic review. Br J Dermatol 2005;152:673-678
31. Arora A, Lowe L, Su L, Rees R, Bradford C, Cimmino VC, et al. Wide excision without radiation for desmoplastic melanoma. Cancer 2005;104:1462-1467
32. Foote MC, Burmeister B, Burmeister E, Bayley G, Smithers BM. Desmoplastic melanoma: the role of radiotherapy in improving local control. ANZ J Surg 2008;78:273-276
33. Zembowicz A, McCusker M, Chiarelli C, Dei Tos AP, Granter SR, Calonje E, et al. Morphological analysis of nevoid melanoma: a study of 20 cases with a review of the literature. Am J Dermatopathol 2001;23:167-175
34. Wong TY, Suster S, Duncan LM, Mihm MC Jr. Nevoid melanoma: a clinicopathological study of seven cases of malignant melanoma mimicking spindle and epithelioid cell nevus and verrucous dermal nevus. Hum Pathol 1995; 26:171-179
35. Dhouib RS, Sassi S, Jbeli A, Driss M, Mrad K, Abbes I, et al. Desmoplastic spitz nevus: report of a case and review of the literature. Pathologica. 2008;100:181-184
36. Collina G. A pigmented lesion. Pathologica. 2008;100:433-434
37. Clark WH Jr. A classification of malignant melanoma in man correlated with histogenesis and biologic behavior, In: Montagna W, Hu F, eds. Advances in the biology of the skin. Vol.VII. New York: Pergamon Press 1967, pp. 621-647.
38. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;172:902-908
39. Clark WH Jr, Elder DE, Guerry D 4th, Braitman LE, Trock BJ, Schultz D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989;81:1893-1904
40. Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996;77:1303-1310